Tavistock Group: Funding, Team & Investors | Startup Intros

Loading organizations...

Tavistock Group: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Dec 1, 2019	Black Diamond Therapeutics	$85.0M Series C	Tavistock Group	Versant Ventures, BVF Partners, Casdin Capital, Deerfield Management, Invus, Janus Henderson Investors, Logos Capital, New Enterprise Associates, Nextech Invest, Perceptive Advisors, RA Capital Management, Roche, Wellington Management
Dec 1, 2018	Relay Therapeutics	$400.0M Series C	Deep Nishar	Abstract Ventures, Alumni Ventures, Andreessen Horowitz, Atomic, DFJ Growth, DST Global, General Catalyst, GV, Khosla Ventures, Kleiner Perkins, Menlo Ventures, Quiet Capital, ZhenFund, Bill Gates, Eric Ries, Jeffrey Lee, Marc Benioff, Othman Laraki, Alexandria Venture Investments, BVF Partners, Casdin Capital, D. E. Shaw Research, EcoR1 Capital, Foresite Capital, Perceptive Advisors
Apr 3, 2018	Poseida Therapeutics	$30.5M Series B	David Hirsch	Malin Corporation, Vivo Capital
Jan 24, 2018	Katerra	$865.0M Series D	SoftBank Investment Advisers	DFJ Growth, DivcoWest, Foxconn, Greenoaks Capital, Khosla Ventures, Navitas Capital
Jan 1, 2017	Avidity Biosciences	$16.0M Series B	Michael Martin	F-Prime Capital Partners, Tony Hsu, Alexandria Venture Investments, Todd Brady, EcoR1 Capital, F-Prime Capital, Moore Venture Partners
May 1, 2016	G1 Therapeutics	$47.0M Series C	Bihua Chen	Catalio Capital, Hatteras Venture Partners, RA Capital, Ryan Allis, AJU IB Investment, Cowen Private Investments, Eshelman Ventures, Franklin Templeton, Lumira Ventures, MedImmune Ventures, Mountain Group Partners, RA Capital Management, Rock Springs Capital
Aug 1, 2015	Syndax Pharmaceuticals	$80.0M Series C	Delos, Fidelity Management & Research Company	aMoon Fund, Domain Associates, InterWest, Osage University Partners, T1D Fund, Vivo Capital, Arrowpoint Partners, BioMed Ventures, Cormorant Asset Management, EcoR1 Capital, Forward Ventures, Greenwood Capital, Jennison Associates, MPM Capital, OrbiMed, RusnanoMedInvest
Nov 12, 2014	Blueprint Medicines	$50.0M Series C	Alex Virgilio	BVF Partners, Casdin Capital, Cowen Healthcare Investments, F-Prime Capital, Nextech Invest, Perceptive Advisors, RA Capital Management, Redmile Group, Sabby Capital, Third Rock Ventures, Wellington Management
Apr 16, 2014	Nexvet	$31.5M Series B	—	Adage Capital Management, Farallon Capital Management, Foresite Capital
Jul 1, 2006	Ambrx	$52.0M Series C	Apposite Capital	Maverick Capital, 5AM Ventures, Aravis, CMEA Capital, Dow Employees Pension Plan, Glynn Capital, Roche, Versant Ventures